Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,134.7
18.5 (0.59%)

 

  • STI Straits Times Index
    3,134.7
    18.5 (0.59%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.9
    8.7 (0.55%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,664.3
    160.3 (0.61%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,978.7
    -12.3 (-0.41%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,472.9
    265.7 (1.20%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,169.6
    11.4 (0.19%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,082.8
    14.7 (0.71%)
    Index delayed 20 minutes
  • XAO XAO
    6,843.2
    79.9 (1.18%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 990.1M
  • Value: 1,160.8M
  • Rise: 178
  • Fall: 130
  • Unch: 524

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.091+0.012
AIMS APAC Reit1.370-0.110
Spackman0.017+0.003
Thomson Medical0.060+0.002
Golden Agri-Res0.210-0.005
YZJ Shipbldg SGD0.970-
Genting Sing0.920-
Mapletree Log Tr1.700+0.030
Jiutian Chemical0.014+0.001
SingTel3.170-

World Indices

World Indices
Name Last Change
Nasdaq 8,148.7 +100.1
HSI 26,664.3 +160.3
HSCEI 10,532.2 +32.0
Jakarta 6,169.6 +11.4
Nikkei 225 22,472.9 +265.7
SSE Comp 2,978.7 -12.3
Shanghai A 3,120.6 -13.0
Shanghai B 270.1 +0.2
PSE Comp 0.0
KOSPI 2,082.8 +14.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AIM IMMUNOTECH INC AIM IMMUNOTECH
Updated on 15 Oct 2019 (End of trading day)
Last (USD): 0.553 Change: -0.027 High: 0.599 Remarks: -
Change (%): -4.59 Low: 0.540
Open 0.550 Yesterday's Close 0.58
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 432,275 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.81858 Trailing EPS (USD) e -0.84102 NAV (USD) b 0.4444
PE a - Trailing PE f - Price / NAV b 1.2453
Dividend (USD) d - Cash In Hand (USD) g 0.0800 Issued & Paid-up Shares c 11,987,800
Dividend Yield (%) d - Price / Cash In Hand g 6.918 Treasury Shares h -
Beta - 75 Daysi 0.317 R-Squared - 75 Days(%)i 0.06 Market Cap (M) 6.634
Beta - 500 Daysi 0.361 R-Squared - 500 Days (%)i 0.05 Enterprise Value (M) 9.878
Piotroski F Score 2 Exchange Code AIM Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 98.6
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 01 Oct 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 03 Sep 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AIM IMMUNOTECH INC NYSE American 6.634 - - 1.2453 -
Industry Biotechnology NYSE American 71.909 - - 2.5271 -
Local Peer PFENEX INC NYSE American 209.408 - - 4.0418 -
Local Peer 22ND CENTURY GROUP INC NYSE American 208.603 - - 3.3476 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 142.041 - 4.574 1.0648 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 128.308 3.587 3.587 1.2761 -
Local Peer NAVIDEA BIOPHARMACEUTICALS INC NYSE American 120.033 - - 52.8571 -
Local Peer NANOVIRICIDES INC NYSE American 109.115 - - 10.2976 -
Local Peer CEL-SCI CORP NYSE American 78.049 - - 68.0782 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 66.220 - - 2.1499 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 50.311 - - 9.8816 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 39.686 - - 1.7537 -
Local Peer IBIO INC NYSE American 35.271 - - 14.3396 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 28.031 - - 0.8647 -
Other Local Peers ORAGENICS INC (NYSE American), ISORAY INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American)
Global Peer AMGEN INC NASDAQ 122,734.807 14.622 15.423 11.3706 2.709
Global Peer GILEAD SCIENCES INC NASDAQ 82,699.185 15.160 13.887 3.6567 3.534
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CSL ASX 114,826.327 42.799 42.799 15.3447 1.049
Global Peer CELGENE CORP NASDAQ 71,547.404 17.684 13.574 7.1184 -
Global Peer ILLUMINA INC NASDAQ 45,888.990 55.556 48.922 10.5930 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 45,274.145 21.596 20.440 8.9299 -
Global Peer BIOGEN INC NASDAQ 41,696.089 9.411 7.876 3.2191 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 33,388.101 13.659 16.135 3.4223 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,442.201 74.184 21.868 4.9383 0.808
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), SEATTLE GENETICS INC (NASDAQ), WUXI BIO (HKEx), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), 3SBIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), IMMUNOMEDICS INC (NASDAQ), NATERA INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MYRIAD GENETICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), 10X GENOMICS INC (NASDAQ), XENCOR INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), EIDOS THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), OPKO HEALTH INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), POLYNOVO LIMITED (ASX), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INTREXON CORP (NASDAQ), VIELA BIO INC (NASDAQ), VIVA BIOTECH (HKEx), SANGAMO THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), EPIZYME INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), OMEROS CORP (NASDAQ), AVITA MEDICAL LTD (ASX), RHYTHM PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), MESOBLAST LTD (ASX), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CORTEXYME INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), NEXTCURE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARVINAS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), RETROPHIN INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), VIKING THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CKLIFE SCIENCES (HKEx), ASCLETIS-B (HKEx), STEMLINE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ESSEX BIO-TECH (HKEx), MERIDIAN BIOSCIENCE INC COM (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SYNTHORX INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), AGENUS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), BELLUS HEALTH INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), XBIOTECH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), LEE'S PHARM (HKEx), KADMON HLDGS INC (NYSE), PREVAIL THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEXT SCIENCE LTD (ASX), MEDICINOVA INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), DERMIRA INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), GERON CORP (NASDAQ), PDL BIOPHARMA INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), RESTORBIO INC (NASDAQ), TELIX PHARMACEUTIC (ASX), COMPUGEN (NASDAQ), RECRO PHARMA INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MANNKIND CORPORATION (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), DPHARMA (Bursa), GALECTIN THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ATHERSYS INC (NASDAQ), KAMADA (NASDAQ), CHIASMA INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), BBI LIFE SCI (HKEx), NEUROINSIGHTS NEUROTECH (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AFFIMED N V (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), CUE BIOPHARMA INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), RESAPP HEALTH LIMITED (ASX), XOMA CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), IMV INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NANTKWEST INC (NASDAQ), SESEN BIO INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), PHYLOGICA LIMITED (ASX), CHIMERIX INC (NASDAQ), TREVENA INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), VACCINEX INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), ARAVIVE INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), CURIS INC (NASDAQ), OTONOMY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), IMMUTEP LTD (ASX), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), PORT (SET), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), CT ENTERPRISE (HKEx), ORTHOCELL LIMITED (ASX), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), IMUGENE LIMITED (ASX), CIDARA THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), BIONOMICS LTD (ASX), INMUNE BIO INC (NASDAQ), EVOGENE LTD (NASDAQ), IVERIC BIO INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MEMPHASYS LTD (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), VERMILLION INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), SAVARA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), REGENT PACIFIC (HKEx), RHINOMED LIMITED (ASX), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIOTRON (ASX), FIBROCELL SCIENCE INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ZAFGEN INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), BIOSINO BIO-TEC (HKEx), CONTRAFECT CORP (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), EXTRAWELL PHAR (HKEx), KAZIA THERAPEUTICS LIMITED (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), CO DIAGNOSTICS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), SOLIGENIX INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIOCEPT INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ADALTA LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), VAXART INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), OCUGEN INC (NASDAQ), IMMURON LIMITED (ASX), PRECIPIO INC (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), DARE BIOSCIENCE INC (NASDAQ), Suntar Eco-City^ (SGX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), REGENEUS LTD (ASX), GENETIC TECHNOLOGIES (ASX), TOCAGEN INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CELLMID LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), ATYR PHARMA INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), CLEVELAND BIOLABS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), MEDIBIO LIMITED (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), MGRC (Bursa), ANATARA LIFESCIENCES LTD (ASX), BIOXYNE LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), ADVAXIS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), HAO WEN HLDGS (HKEx), CYCLACEL PHARMA IN (NASDAQ), QT Vascular (SGX), AVECHO BIOTECHNOLOGY LTD (ASX), OPGEN INC (NASDAQ), TROVAGENE INC (NASDAQ), MEGASUN (Bursa), XENETIC BIOSCIENCES INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), BIONANO GENOMICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), CCP TECHNOLOGIES LTD (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), NOVITA HEALTHCARE LTD (ASX), SPHERIX INC (NASDAQ), NANOLLOSE LTD (ASX), NEURALSTEM INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), BPH ENERGY LIMITED (ASX), PLUS THERAPEUTICS INC (NASDAQ), ALCHEMIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.020
-3.42 %
10 Days --0.072
-11.46 %
20 Days --1.102
-66.56 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.522 - 3.600 Change From 1 Year Low +0.031 % Change From 1 Year Low (%) +6.02
Change From 1 Year High -3.047 % Change From 1 Year High (%) -84.63
2 Years Range 0.522 - 3.600 Change From 2 Years Low +0.031 % Change From 2 Years Low (%) +6.02
Change From 2 Years High -3.047 % Change From 2 Years High (%) -84.63
5 Years Range 0.522 - 3.600 Change From 5 Years Low +0.031 % Change From 5 Years Low (%) +6.02
Change From 5 Years High -3.047 % Change From 5 Years High (%) -84.63
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Oct 2019 0.550 0.599 0.540 0.553 432,275 -
14 Oct 2019 0.590 0.600 0.570 0.580 213,325 -
11 Oct 2019 0.610 0.627 0.575 0.585 286,448 -
10 Oct 2019 0.690 0.690 0.600 0.600 625,991 -
09 Oct 2019 0.576 0.580 0.550 0.573 84,298 -
08 Oct 2019 0.660 0.660 0.573 0.573 177,275 -
07 Oct 2019 0.570 0.632 0.544 0.590 362,796 -
04 Oct 2019 0.630 0.630 0.522 0.550 231,275 -
03 Oct 2019 0.630 0.644 0.560 0.603 265,557 -
02 Oct 2019 0.710 0.710 0.620 0.625 476,500 -
01 Oct 2019 0.770 0.787 0.710 0.710 427,115 -
30 Sep 2019 0.762 0.790 0.703 0.762 475,432 -
27 Sep 2019 0.730 0.790 0.710 0.743 693,778 -
26 Sep 2019 0.835 0.835 0.672 0.705 946,582 -
25 Sep 2019 0.850 1.015 0.760 0.833 3,389,427 -
24 Sep 2019 2.300 2.470 1.400 1.470 8,703,100 -
23 Sep 2019 1.820 1.850 1.660 1.720 185,723 -
20 Sep 2019 2.200 2.210 1.820 1.850 503,611 -
19 Sep 2019 3.360 3.600 2.090 2.200 8,896,997 -
18 Sep 2019 1.770 1.800 1.620 1.655 70,649 -
17 Sep 2019 1.850 1.850 1.750 1.770 30,178 -
16 Sep 2019 1.810 1.890 1.810 1.840 53,293 -
Summary
Current 2 Weeks
(02 Oct 2019 to 15 Oct 2019)
0.710 0.710 0.522 0.553 3,155,740 -
Previous 2 Weeks
(18 Sep 2019 to 01 Oct 2019)
1.770 1.800 0.522 0.710 24,292,414 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.